Study of angiogenic signaling pathways in hemangioblastoma

Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma

(2016) Roeliene C. Kruizinga et al.   Familial Cancer

VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside

(2016) Marlous Arjaans et al.   Oncotarget

Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma

(2015) Nicole Lambertz et al.   BMC CANCER

Recent advance in molecular angiogenesis in glioblastoma: the challenge and hope for anti-angiogenic therapy

(2015) Meng Zhang et al.   Brain Tumor Pathology

Erythropoietin Stimulates Tumor Growth via EphB4

(2015) Sunila Pradeep et al.   CANCER CELL

VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFβR signaling-dependent manner

(2015) Kien Pham et al.   CANCER LETTERS

p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk

(2015) Valeria Barresi et al.   JOURNAL OF NEURO-ONCOLOGY

Current status and future directions of anti-angiogenic therapy for gliomas

(2015) Wolfgang Wick et al.   NEURO-ONCOLOGY

Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth

(2015) Yuan Zhu et al.   NEURO-ONCOLOGY

Imaging diagnosis and the role of endovascular embolization treatment for vascular intraspinal tumors

(2015) Marlise P. dos Santos et al.   Neurosurgical Focus

The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study

(2015) Jin-feng Zhang et al.   TUMOR BIOLOGY

Upregulation of hypoxia-inducible factors and autophagy in von Hippel–Lindau-associated retinal hemangioblastoma

(2014) Yujuan Wang et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Sporadic hemangioblastomas are characterized by cryptic VHL inactivation

(2014) Ganesh M Shankar et al.   Acta Neuropathologica Communications

The VEGF pathway in lung cancer

(2013) Michalis Alevizakos et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Dll4-Notch signaling in regulation of tumor angiogenesis

(2013) Zhaoguo Liu et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Clinical implications of DLL4 expression in gastric cancer

(2013) Sumiya Ishigami et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme

(2013) N. El Hindy et al.   NEURO-ONCOLOGY

The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis

(2012) Lei Yu et al.   GYNECOLOGIC ONCOLOGY

The double-edged sword of Notch signaling in cancer

(2012) Andrew P. South et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Notch receptor and effector expression in von Hippel-Lindau disease–associated central nervous system hemangioblastomas

(2011) Marsha J. Merrill et al.   JOURNAL OF NEUROSURGERY

Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer

(2011) Dan R Robinson et al.   NATURE MEDICINE

Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis

(2010) Dusan Djokovic et al.   BMC CANCER

Overexpression and activation of epidermal growth factor receptor in hemangioblastomas

(2010) Gregory J. Chen et al.   JOURNAL OF NEURO-ONCOLOGY

Angiogenesis: A Team Effort Coordinated by Notch

(2009) L.-K. Phng et al.   DEVELOPMENTAL CELL

Analyzing real-time PCR data by the comparative CT method

(2008) Thomas D Schmittgen et al.   Nature Protocols